ISPOR Europe 2024 News Center

Explore the news and reporting from ISPOR Europe 2024 in the News Center with curated stories on cutting-edge topics from the conference.

ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being

The ISPOR Europe 2024 conference—Generating Evidence Toward Health and Well-Being—centers on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe. News from the conference will be posted as stories are published.

ISPOR Europe 2024: Reflections From a First-Time Attendee  [The Evidence Base]

Economic Modeling in Healthcare: Harnessing Stakeholder Insights for Real-World Impact  [The Evidence Base]

Payer Perspectives on Key Challenges in Healthcare Decision-Making: Actionable Insights for Life Sciences Companies [The Evidence Base]

A Tale of Two Conferences: AI for Systematic Literature Reviews and Evidence Synthesis at ISPOR Europe 2024 [The Evidence Base]

Bridging Privacy and Research in Real-World Evidence – A Global Data and Secured Data Environment Technology Framework [The Evidence Base]

How Can Lessons Learned from National System Reforms Guide Response to the EU HTAR? [Navlin Daily]

ISPOR Europe 2024 Daily Round-Ups: Day 3 [The Evidence Base]

Inside the Third Plenary: Balancing Costs and Evidence for Affordable Medicines and Stronger EU HTA [The Evidence Base]

Rise in EU Pharma Spending Fuels Calls for Transparency on Public Funding  [Navlin Daily]

Pharma Needs to be “Realistic” with JCA Submission Timelines – ZIN Senior Advisor [Navlin Daily]

Does Accelerated Approval for Oncology Drugs Need Reform? [Navlin Daily]

Outcomes-Based Pricing "Making a Return" in England, Says NICE's David Thomson [Navlin Daily]

[Video] Final Impressions from ISPOR Europe 2024 [RTI(h)(s)] 

Taiwan "Likely to Use JCA in HTA Reviews in the Future" [Navlin Daily]

Growth and Challenges in Cross-Border Collaborations [Navlin Daily]

First Medicare Negotiation Round was "Outcomes Driven, not Process Driven"  [Navlin Daily]

ISPOR Europe 2024 Daily Round-Ups: Day 2 [The Evidence Base]

Inside the Second Plenary: Ensuring Readiness for EU HTAR  [The Evidence Base]

Upcoming Danish Medicines Council Chair Says EMA Should "Step Up"on Confirmatory Trials  [Navlin Daily]

Belgian Health Official Worries Uncertainty Can be Seen as "Negotiating Chip" [Navlin Daily]

Companies Working "at Risk" Due to Lack of Transparency in HTAR - Roche Head [Navlin Daily]

Cost-Saving Potential of RDP Change in EU Legislation "Quite Limited" - TLV Director  [Navlin Daily]

ISPOR Europe 2024 Daily Round-Ups: Day 1  [The Evidence Base]

Inside the First Plenary: Navigating Evidence-Price Challenges for Patient Access  [The Evidence Base]

ISPOR Europa: se Avanza en Acuerdos de Compra, Falta Transparencia  [DiarioFarma]

Round-Up of the ISPOR Real-World Evidence Summit 2024  [The Evidence Base]

Countdown to ISPOR Europe 2024  [The Evidence Base]

Navigating the ISPOR Europe 2024 Conference Program – Focus on Real-World Data and Real-World Evidence [The Evidence Base]

ISPOR Europe 2024: Navigating the Conference Program – Focus on Drug Pricing  [The Evidence Base]

ISPOR Europe 2024: Navigating the Conference Program – Focus on Artificial Intelligence [The Evidence Base]

ISPOR Europe 2024: Navigating the Conference Program – Focus on Health Equity [The Evidence Base]

ISPOR Europe 2024: Navigating the Conference Program – Focus on Patient Centricity  [The Evidence Base]

ISPOR Europe 2024: Navigating the Conference Program – Focus on Health Technology Assessment and Health Policy [The Evidence Base]

ISPOR Real-World Evidence Summit 2024: Event Preview [The Evidence Base]

Spotlight on ISPOR Europe 2024: An Interview with ISPOR's Rob Abbott and Laura Pizzi [The Evidence Base]

New Study Shows NICE Advice Support Can Reduce Appraisal Timelines by 3 Months [WiredGov]

Preview of ISPOR Europe 2024 Plenary Sessions [The Evidence Base]

First Look at the ISPOR Europe 2024 Conference Program [The Evidence Base]

ISPOR’s New Strategic Plan Underscores Importance of Accessible, Effective, Efficient, and Affordable Global Healthcare [The Evidence Base]

ISPOR and ACCESS Forum Announce Collaboration [Fox 40]

Planning Ahead and Key Dates for ISPOR Europe 2024  [The Evidence Base]

Photo Gallery

Additional News From the Conference

CAR T-Cell Therapy Insights Recognized at ISPOR Europe [Premier Research]

[Video]Insights from ISPOR Europe 2024 with CHEORS Chief Scientific Officer, John Cook [BioBridges]

Insights from ISPOR Europe 2024 – Focus on JCA, HTAR, and Emerging Trends [Blue Matter Consulting]

[Video] AI and the Evolution of Market Access: What Comes Next? [MArS]

Despite Recent Sharp Decline in COVID-19 Patients, Social Losses of More Than 7 Trillion Won Reported Last Year Alone [Maeil Business Newspaper]

Genesis Research Group ISPOR Europe Presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ Features in Scientific Publication [PMLiVE]

New Tool Launched to Help Navigate Incoming JCA Regulations [European Pharmaceutical Manufacturer]

[Video] Highlights from ISPOR Europe 2024 [Mtech Access]

AcuCort AB: AcuCort Presented at ISPOR Europe 2024 in Barcelona [Inderes]

[Video] Market Access 4.0: Interview with Dr. Stefan Walzer at ISPOR Europe [MArS]

Cognito Therapeutics Presents Early-Stage Cost-Effectiveness Analysis of Spectris™ Therapy in Alzheimer’s Disease at ISPOR Europe 2024 [Business Wire]

Vall d’Hebron Presenta Cuatro Comunicaciones Sobre sus Proyectos de Atención Basada en Valor en el Congreso Europeo de Economía y Resultados en Salud ISPOR [Vall d’Hebron]

Partners4Access Will Present Three Thought Provoking Posters at ISPOR Europe 2024 in Barcelona [Partners4Access]

Data Leaders Network to Attend ISPOR Europe 2024 [Data Leaders Network]

ISPOR Europe 2024: Driving Health Innovation [ESiOR]

IHE (The Swedish Institute for Health Economics) at ISPOR Europe in Barcelona [iHE]

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development [PMLiVE]

The National Institute for Health and Care Excellence (NICE) Partners Presenting EDiHTA at ISPOR Europe 2024 [EDiHTA] 

Healthcare Economists' ISPOR Europe Panels [Healthcare Economist]

Meet the Quantify Team at ISPOR Europe! [Quantify]

Join AMICULUM at ISPOR Europe 2024 [PMLiVE] 

Flatiron Health Announces Research to be Presented at ISPOR Europe 2024 Conference [Yahoo! Finance]

Syneos Health Attends ISPOR Europe [Syneos]

Discover Cencora at ISPOR Europe [Cencora]

RTI Health Solutions Attending ISPOR Europe 2024 [RTI Solutions]

Curta Presenting at ISPOR Europe 2024 [Curta]

Evidera Attending ISPOR Europe [Evidera]

MedEngine Attending ISPOR Europe [MedEngine]

Mtech Access Exhibiting at ISPOR in Europe [PMLive]

AcuCort Presents Study Results at the ISPOR Scientific Conference in Barcelona [AcuCort]

AHI to Unveil Cost-Saving Health Tech at ISPOR Europe [TipRanks]

HEOR News Desk

HEOR News Desk

ISPOR News Webpage

ISPOR News

Thank You to ISPOR Europe 2024 Media Partners:

A special thank you to ISPOR Europe 2024's Media Partners—The Evidence Base,  Journal of Medical Economics, and PharmaBoardroom—and to all the media outlets who are reporting on the conference.

Disclaimer:

The reporting on ISPOR Europe 2024 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.